The nhlbi requires the gene therapy resource program (gtrp) support translational gene therapy research by providing resources and services from three core laboratories: 1.) pharmacology and…
Ended Awarded Last action
- Contract number
- 75N92019F00074
- Awardee
-
Social & Scientific Systems, Inc. UEI XKMBEM2BTLK3 Part of DLH Holdings Corp
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,888,003
Award facts
- Opportunity
-
- Gene Therapy Resource Program (GTRP) Pre-Solicitation · HHSN26818HV00005R · Posted Sep 19, 2017
- Gene Therapy Resource Program (GTRP) Award Notice · Posted Dec 19, 2018
- Contract value 100% obligated
- $2,888,003.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Silver Spring, MD 20910, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$149,749 | |
| Funding Only Action | -$29,872 | |
| Supplemental Agreement for work within scope | $22,431 | |
| Exercise an Option | $564,125 | |
| Exercise an Option | $551,275 | |
| Exercise an Option | $644,767 | |
| Funding Only Action | $168,755 | |
| Exercise an Option | $413,021 | |
| Original award | $703,250 |
About this award
This federal contract award is for the Gene Therapy Resource Program (GTRP) Clinical Coordinating Center, which provides administrative support for translational gene therapy research. The contract was awarded to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp., a technology-enabled business process and program management solutions provider. The contract has a ceiling value of $2,888,003.09 and was awarded by the National Heart, Lung and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH). The contract is for the delivery of services through three core laboratories: Pharmacology and Toxicology, Preclinical Vector, and the Clinical Coordinating Center. This contract is not designated as a set-aside and is a cost-plus-fixed-fee type contract with a performance period ending on December 18, 2023.
Description
The nhlbi requires the gene therapy resource program (gtrp) support translational gene therapy research by providing resources and services from three core laboratories: 1.) pharmacology and toxicology core laboratory, 2.) preclinical vector core laboratory, 3.) clinical coordinating center (CCC), which is not required to have any laboratory capabilities.
Quick answers
Who was awarded contract 75N92019F00074?
75N92019F00074 was awarded to Social & Scientific Systems, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on December 19, 2018.
How much is contract 75N92019F00074 worth?
The government has obligated $2,888,003 on 75N92019F00074.
Is contract 75N92019F00074 an order under another contract?
Yes. 75N92019F00074 is a delivery order under 75N92019D00015, an indefinite delivery contract.
Was contract 75N92019F00074 competed?
The extent of competition for 75N92019F00074 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award